Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA response elements in beta-cell gene promoters are specific nucleotide sequences within the regulatory regions of genes that define the identity and function of pancreatic beta-cells, such as the insulin (INS) gene. These elements, including the A-box, E-box, and cAMP response elements (CRE), serve as critical binding sites for a network of transcription factors like PDX1, MAFA, and NEUROD1 (PMID: 11909530). By integrating signals from glucose metabolism and hormonal pathways, these elements ensure that insulin synthesis and secretion are precisely regulated to maintain glucose homeostasis (PMID: 15615631). In the pathogenesis of Type 2 Diabetes, chronic stress leads to the loss of transcription factor binding at these sites, resulting in beta-cell dedifferentiation and functional failure (PMID: 23063597). While these DNA sequences are not direct targets for conventional small-molecule drugs, they are the functional endpoints for therapies like GLP-1 receptor agonists, which enhance the transcriptional activity at these promoters via downstream signaling cascades (PMID: 19366864). Consequently, these elements are central to research in regenerative medicine and gene therapy aimed at restoring insulin production in diabetic patients.
Modulation of transcription factor binding to promoter elements to regulate insulin gene expression.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA response elements in beta-cell gene promoters.